Use of chimeric antigen receptor NK-92 cells to target mesothelin in ovarian cancer-Reference-Cited by-同舟云学术

Use of chimeric antigen receptor NK-92 cells to target mesothelin in ovarian cancer

Published:2020-03 Issue:1 Volume:524 Page:96-102
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Cao Bihui,Liu Manting,Wang Lu,Liang Baoxia,Feng Yunfei,Chen Xiaopei,Shi Yuanyuan,Zhang Jinling,Ye Xiaodie,Tian Yu,Zhi Cheng,Li Junping,Lian Hui,Wu Qingde,Zhang Zhenfeng

Funder

National Natural Science Foundation of China

Guangzhou Municipal Science and Technology Project

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference21 articles.

1. Cancer statistics, 2019;Siegel;CA A Cancer J. Clin.,2019

2. Ovarian cancer statistics, 2018;Torre;CA A Cancer J. Clin.,2018

3. Rethinking ovarian cancer: recommendations for improving outcomes;Vaughan;Nat. Rev. Cancer,2011

4. CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia;Brentjens;Sci. Transl. Med.,2013

5. Chimeric antigen receptor-modified T cells for acute lymphoid leukemia;Grupp;N. Engl. J. Med.,2013

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biotechnology Advances in Disease Treatment;International Encyclopedia of Public Health;2025

2. NK cell line modified to express a potent, DR5 specific variant of TRAIL, show enhanced cytotoxicity in ovarian cancer models;Heliyon;2024-08

3. CAR-T therapy for ovarian cancer: Recent advances and future directions;Biochemical Pharmacology;2024-08

4. Development of glypican-3-specific chimeric antigen receptor-modified natural killer cells and optimization as a therapy for hepatocellular carcinoma;Journal of Leukocyte Biology;2024-06-26

5. A new vision of the efficacy of both CAR-NK and CAR-T cells in treating cancers and autoimmune diseases;Medical Oncology;2024-04-24